<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0" xml:base="http://www.fda.gov/">
<channel>
<title>Approval letter Testing</title>
<description> <a href="https://testingweb001.netlify.app">click here</a>Drug approval letters and documents</description>
<language>en</language>
 
    <item>
<title>Supplement Approval for the Drug</title>
<description><a href="https://testingweb001.netlify.app/docs/Document1.pdf">click here</a>Use of Baxter MiniCap Extended Life PD Transfer Sets during peritoneal dialysis may expose patients to higher than allowable NDL-PCBAs.</description>
<pubDate>Mon, 31 Mar 2025 00:00:00 EDT</pubDate>
<dc:creator>FDA</dc:creator>
<guid isPermaLink="true">https://www.fda.gov/medical-devices/medical-device-recalls/peritoneal-dialysis-set-correction-baxter-issues-correction-minicap</guid>
</item>
 
    <item>
<title>Supplement Approval for the Drug2</title>
<link>https://testingweb001.netlify.app/docs/Document2.pdf</link>
<description>Approval document for Drug2.</description>
<pubDate>Tue, 01 Apr 2025 00:00:00 EDT</pubDate>
<dc:creator>FDA</dc:creator>
<guid isPermaLink="false">drug2-2025-approval</guid>
</item>
 
    <item>
<title>Supplement Approval for the Drug3</title>
<link>https://testingweb001.netlify.app/docs/Document3.pdf</link>
<description>Approval document for Drug3.</description>
<pubDate>Wed, 02 Apr 2025 00:00:00 EDT</pubDate>
<dc:creator>FDA</dc:creator>
<guid isPermaLink="false">drug3-2025-approval</guid>
</item>
</channel>
</rss>

 
